Is Ovarian Cancer Linked to Ovulation?

July 24, 2012

(Medical Xpress) -- Could ovulation be the link to ovarian cancer? Joanna Burdette of the University of Illinois at Chicago College of Pharmacy thinks it might be, and she's working to find out.

Burdette, assistant professor of and pharmacognosy at UIC, is conducting new research to discover if increases a signaling pathway that transforms cells of the ovary surface or the lining of the into .

Burdette has received a four-year $720,000 grant from the of Illinois for her research, which focuses on epithelial cells, or surface and lining cells, in this case, of the .

"One of the most confounding issues of ovarian cancer is the concept that the epithelial subtype responsible for the disease is still not completely known," Burdette says.

"Preventing the disease might be attainable, but we first need to find out where the tumors arise," she said. "Past research has concluded that the cancer occurs from either the epithelial cells on the ovary, fallopian tube, or both."

Using three-dimensional developed in her laboratory to monitor early cell-signaling pathways responsible for the disease, Burdette is investigating how cells become cancerous and whether hormones are part of the process.

Ovulation is thought to contribute to ovarian cancer, she says, by spurring ; by stimulating cell-signaling pathways in response to pituitary hormones; and by damaging DNA, due to the inflammatory that results from release of the egg from its follicle.

Burdette is focusing on one particular signaling molecule, called Akt.

"Akt is one of the most frequently activated pathways in ovarian cancer," Burdette said. The gene that produces the Akt molecule, she says, is dialed up in response to oxidative stress or the hormones that trigger ovulation.

Burdette and her co-workers plan to grow both the ovarian and the tubal epithelium as 3-D organ cultures, transform the normal cells into cancer cells, and determine which signaling pathways are activated by the cancerous transformation. This should confirm whether Akt is activated and whether it thwarts the DNA-repair mechanism differently in ovarian epithelial cells than in cells of the Fallopian tubes. Mutations in that DNA-repair mechanism are often found in women who have ovarian cancer.

Ovarian cancer strikes about 22,000 women in the U.S. each year, according to the Ovarian Cancer Research Fund. A woman's lifetime risk of developing ovarian cancer is 1 in 17, with most cases developing after menopause. Symptoms include bloating, pelvic or abdominal pain, feeling of fullness, or urinary tract issues.

Few treatments were available in the 1970s. Diagnosis was not possible until the cancer was advanced, and few women survived longer than six months. Today, almost half of patients are alive five years after diagnosis.

Burdette hopes her work will further increase the life expectancy of ovarian cancer patients.

"Sadly, the overall incidence of ovarian-cancer death has not changed much in 30 years," she said.

Explore further: Ovarian cancer arises in fallopian tube of knockout mice

Related Stories

Ovarian cancer arises in fallopian tube of knockout mice

February 13, 2012
(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...

Researchers exploring important new insight into ovarian cancer

November 7, 2011
Researchers from the Harper Cancer Research Institute, a partnership between the University of Notre Dame and Indiana University School of Medicine-South Bend, have uncovered a key element that plays a role in the spread ...

Experimental drug inhibits cell signaling pathway and slows ovarian cancer growth

April 15, 2011
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.